Challenging case presentation

Slides:



Advertisements
Similar presentations
Angioclub Case Series: Aortic Pathology Candace L. White MA, MD Mount Sinai Medical Center of Florida.
Advertisements

Cardiology Jeopardy Don’t Go Failing My Heart Acute Coronary Syndromes
Call for CASES Leszek D. Stachaczyk, MD Pawel Buszman, MD, FESC, FSCAI American Heart of Poland, Ustroñ, Poland & CCU, Upper-Silesian Center of Cardiology,
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total.
C. Graidis, D. Dimitriadis, A. Ntatsios, V. Karasavvides
NYU Medical Grand Rounds Clinical Vignette Jennifer Lue, MD PGY-2 9/11/2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
VULNERABLE PLAQUES: Pertinent doubts and solutions in interventional cardiology EuroPCR Paris, 16 May 2006.
Medical Grand Rounds Clinical Vignette October 15 th, 2008 Srikant Duggirala, M.D.
Management of Iliac Artery Aneurysms. Etiology Idiopathic – Remote collagen vascular disease Idiopathic – Remote collagen vascular disease Atherosclerosis,
New strategies and perfusion/aspiration devices for primary PCI Sandra Garcia Cruset, PhD. Cordynamic B.U. Marketing Manager.
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
Saqib Chowdhary Wythenshawe Hospital STENT THROMBOSIS How Do IVUS & OCT Help.
Vertebral PTA: Indications and Technique Patrick L. Whitlow, MD Director, Interventional Cardiology The Cleveland Clinic Foundation Patrick L. Whitlow,
Columbia University Medical Center Cardiovascular Research Foundation New York City, NY Akiko Maehara, MD Use of IVUS Reduces Stent Thrombosis and Myocardial.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Real-world clinical experience with an everolimus eluting platinum chromium stent with an abluminal biodegradable polymer – a report from the Swedish Coronary.
Intravascular ultrasound (IVUS) in percutaneous coronary intervention – summary of key articles While angiography is routinely used for assessment of CAD,
Intravascular ultrasound (IVUS) in the treatment of long and diffuse lesions– summary of key articles Prepared by Radcliffe Cardiology 21 November2016.
Adel Gamal, MD and Mohamed Saber, Msc
Alaa gabi, md sUPERVISOR: RAMEEZ SAYYED, MD.
My initial ABSORB experience Assoc. Prof. I. Petrov
Abed Dehnee MD, Rajiv Patel MD, Dan Tsyvine MD, Edo Kaluski, MD
Emory University School of Medicine
POSTER 2 7:17 – 7:24 Mid-Term Outcomes of the ABSORB® Bioresorbable Scaffold in STEMI patients: initial experience Presenter: Fabien Picard  Authors:
Coronary stent immobilisation with rapid ventricular pacing technique via coronary guidewire in non-ST elevation myocardial infarction Dr Zaid Iskandar.
Acute Myocardial Infarction and Cardiac Arrest Due to Coronary Artery Perforation After Mitral Valve Surgery : Successful Treatment with a Covered Stent.
Interesting Case Presentation
Clinical Presentation
(DES)+BVS +DCB for long diffuse LAD disease
Tarek Abou Ghazala, MD, FACC, FSCAI
CRT 2017 Interventional Challenging Case Anterior ST- Elevation Myocardial Infarction Resulting From Acute Occlusion of Left Internal Mammary Artery Graft.
Treatment of Giant Coronary Aneurysms
Acute Arterial Clot Management
The Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel
Meruzhan Saghatelyan, MD, Interventional cardiologist
Philip Urban, Philippe Garot, Damras Tresukosol,
Coronary bifurcation wide-neck aneurysm successfully treated by provisional Y-stent-assisted coil embolization Gregory A. Sgueglia, MD, PhD Interventional.
Edward Howard MBChB(Hons) PhD Robert Lager MD Augusto Pichard MD
The Winking Saphenous Vein Graft: Acute Aorto-Vein Graft Anastomotic Torsional Kink causing Dynamic Systolic Compression Complicating Vein Graft PCI Dr.
LONG-DES II Trial Randomized Comparison of the Efficacy of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in the Treatment of Long Native Coronary.
BVS Expand: First Results of Wide Clinical Applications
Complex PCI to CTO lesion in RCA with nightmares complications
Late stent thrombosis Ashish shah, Tim Kinnaird, W J Penny
PCI in patients with cardiogenic shock associated with acute occlusion of the left main coronary artery.
Case Presentation CRT Sumith Aleti.
Session Date: 28th Nov’14 Session Time: 14:30 – 16:00
On behalf of J. Belardi, M. Leon, L. Mauri,
Single Stage CABG and Peripheral Arterial Bypass for Combined Coronary and Peripheral Arterial Disease Divya Arora, Ashok Chahal and Shamsher Singh Lohchab.
Acute Myocardial Infarction and Cardiac Arrest Due to Coronary Artery Perforation After Mitral Valve Surgery : Successful Treatment with a Covered Stent.
Fractional Flow Reserve Workshop
Case presentantion 73-year old female
Circ Cardiovasc Interv
Catheter-Based Treatment of Coronary Artery Disease
Spontaneous Coronary Artery Dissection: Good Long-term Outcome with IVUS-Guided Diagnosis and Management Italo Porto Interventional Cardiology Unit Università.
Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study  Jiang.
Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-year Outcomes of the EVERBIO.
Impact of Platelet Reactivity Following Clopidogrel Administration
Bifurcation Disease: Simulation Training Curriculum
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
What oral antiplatelet therapy would you choose?
Management of acute type B aortic dissection
Presented at TCT 2006.
Martin B. Leon, David R. Holmes, Dean J. Kereiakes, Jeffrey J
Maintenance of Long-Term Clinical Benefit with
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Ahmed A. Khattab, MD For the German Cypher Registry Investigators
ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs
ISAR-LEFT MAIN 2 Randomized Trial Zotarolimus- vs
Presentation transcript:

Challenging case presentation Alok Sharma University of Minnesota

Disclosures I have no disclosures pertinent to this talk.

HPI: 67 y/o male presented to the ER with left wrist pain. Diagnosed with septic arthritis after arthrocentesis. Complained of exertional chest pressure along with atypical sharp pain with lying down and deep inspiration. Past Medical History: History of solitary kidney, traumatically injured in 1995. Initiated on hemodialysis in 2004. Diseased donor kidney transplant in 2005 which failed in 2006. Initiated on peritoneal dialysis in 2006. Hypertension. Hyperlipidemia. Extensive h/o CAD

Coronary artery disease history 7/2006: NSTEMI with PCI of proximal LAD with Sirolimus (Cypher) 3 x 33 mm DES and PCI of proximal to mid RCA with 4 x 20 mm chromium cobalt BMS. 12/15/2011: NSTEMI with 95% ostial RCA and 70% in-stent restenosis mid RCA. 4.0x 12 mm Everolimus eluting stent (Promus Element) to proximal RCA 3.5 x 10 mm Everolimus eluting stent to mid RCA.

1/12/2012: NSTEMI secondary to thrombotic occlusion of prox RCA stent, possible clopidogrel noncompliance. Aspiration thrombectomy with restenting ostial-proximal RCA with overlapping 3.5 x 12 mm and 4 x 12 Everolimus DES (promus element). Switched to Prasugrel. Massive lower GI Bleed requiring 9 U of PRBCs, POD #2 Colonoscopy: 2 active AVMs, photocoagulated / clipped. Switched back to Clopidogrel

1/25/2012: NSTEMI with in-stent thrombosis proximal RCA Aspiration thrombectomy IVUS: ostial segment not stented, stent gap between proximal and mid segments. Placement of 4.0 x 20 mm Everolimus DES (Promus Element) from ostial to prior distal stent edge. IVUS: good stent expansion. Plavix non responder and switched to prasugrel

3/7/2012: Recurrent NSTEMI, acute thrombotic occlusion proximal RCA CT Surgery consulted but hemodynamic instability prompted repeat PCI Emergent thrombectomy and placement of 4.0 x 28 mm BMS (vision) stent. IVUS: small area of mal-apposition in the mid segment. Post dilated at high pressure with good result. Switched to prasugrel 10 mg BID.

7/9/2012: NSTEMI with significant in-stent restenosis of proximal RCA Placement of 3.5 x 26 mm Zotarolimus eluting stent (Resolute).

Now Back to current presentation……. Physical exam: BP: 110/60 HR: 80 in sinus rhythm. Mild distress. Normal JVP, no murmurs. Two component friction rub best over the right third intercostal space. Lungs clear. EKG showed no significant ST-T changes. Troponin I was 0.08 ng/ml. Worsening chest pain and extensive prior CAD history, urgent coronary angiography was performed.

Coronary Angiogram Right radial approach 5F. Stent fracture in the proximal RCA stent with clear separation of the proximal and distal portions of the stents. (Type IV stent fracture). At the site of stent fracture a large expanding pseudoaneurysm of the proximal RCA. Pseudoaneurysm measured 15 mm in maximum dimension. Right radial approach via 4 F JR4 and JL4. Angiogram showed small aorto-ostial dissection flap in the inferior border at the proximal edge of the ostial stent .

Stent Fracture

Cardiothoracic surgery was consulted emergently for coronary artery bypass and resection of pseudoaneurysm. Deemend high risk surgical candidate due to untreated wrist infection and being on prasugrel. Therefore, we decided to put a polytetrafluoroethylene-covered stent (JOSTENT®, Abbott Vascular; Redwood City, Calif ) to treat the pseudoaneurysm. Converted from right radial to 7 F right femoral access.

Successfully treated with 4 Successfully treated with 4.0 x 19 mm covered JoStent and post dilated with 4 X 8 mm non compliant balloon at 18 ATM. Perforation was well sealed. No edge dissection with TIMI 3 flow in distal RCA.

Clinical Course Echo showed no pericardial effusion. Ejection fraction was 45% with inferior wall hypokinesis which was old. Doing well with no clinical events 7 months post procedure.

Conclusions Coronary artery stent fracture occurs rarely (0.6-8%). Stent fracture results in complications that include instent restenosis, stent thrombosis, acute coronary syndromes, sudden cardiac death, coronary aneurysms. Common predisposing factors for stent fracture. - RCA location. - Overlapping stents. - Use of longer stents. - Increased vessel tortuosity. - Overexpansion and overstretching of stent. - Myocardial bridging - Higher incidence with use of drug eluting stents esp Cypher stent.

The reported treatments have been - Conservative (in small pseudoaneurysms) - Surgical - Percutaneous, including coil embolization and covered stent placement. Coronary stent fracture and coronary pseudoaneurysm can be successfully treated with covered stent placement especially when surgery cannot be performed.

References Lee SE, Jeong MH, Kim IS, Ko JS, Lee MG, Kang WY. Clinical outcomes and optimal treatment for stent fracture after drug-eluting stent implantation. J Cardiol Jun 2009;53(3):422–8. Nakazawa G, Finn AV, Vorpahl M, et al. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol Nov 17 2009;54(21):1924–31. Canan T, Lee MS. Drug-eluting stent fracture: incidence, contributing factors and clinical implications. Catheter Cardiovasc Interv Feb12009;75(2):237–45. Review. Lee SH, Park JS, Shin DG, et al. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation. Am J Cardiol Aug 15 2007;100 (4):627–30 Electronic publication 2007 Jun 29. Chhatriwalla AK, Cam A, Unzek S, et al. Drug-eluting stent fracture and acute coronary syndrome. Cardiovasc Revasc Med Jul–Sep 2009;10(3):166–71. Ino Y, Toyoda Y, Tanaka A, Ishii S, Kusuyama Y, Kubo T. Predictors and prognosis of stent fracture after sirolimus-eluting stent implantation. Circ J 2009 Nov;73 (11):2036–41. Umeda H, Gochi T, Iwase M, Izawa H, Shimizu T, Ishiki R. Frequency, predictors and outcome of stent fracture after sirolimus-eluting stent implantation. Int J Cardiol Apr 17 2009;133(3):321–6 Electronic publication 2008 Mar 14. Manola Š, Pintarić H, Pavlović N, Štambuk K. Coronary artery stent fracture with aneurysm formation and in-stent restenosis. Int J Cardiol Apr 15 2010;140(2): e36–9 Electronic publication 2008 Dec 23. Pang JH, Kim D, Beohar N, Meyers SN, Lloyd-Jones D, Yaghmai V. Detection of stent fractures: a comparison of 64-slice CT, conventional cine-angiography, and intravascular ultrasonography. Acad Radiol 2009 Apr;16(4):412–7. Okamura T, HiroT, Fujii T, Yamada J, Fukumoto Y, Hashimoto G. Late giant coronary aneurysm associated with a fracture of sirolimus eluting stent: a case report. J Cardiol 2008 Feb;51(1):74–9. Kim SH, Kim HJ, Han SW, et al. A fractured sirolimus-eluting stent with a coronary aneurysm. Ann Thorac Surg 2009;88:664–5. [12] Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131:149–50.

Acknowledgements Dr. Robert Wilson Dr. Alan Berger Dr. Ganesh Raveendran Dr. Demetris Yannopoulos Dr. Uma Valeti Dr. Mark Pritzker